MetalloBio
PrivateLast Round
Early Funding
May 27, 2026
Est. Valuation
$5.07M
Total Funding Raised
$1.85M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
MetalloBio is a biotechnology company developing novel antimicrobial platform technology to prevent and treat antimicrobial-resistant infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Medical Devices
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MetalloBio Comparables
Compare MetalloBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Allvivo Vascular | 79% | |
| BioCote Limited | 76% | |
| Sciessent | 64% |
MetalloBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | May 27, 2026 | ||||
| Crowdfunding | Dec 19, 2024 | ||||
| Grant | Aug 7, 2024 | ||||
| Grant | Sep 9, 2021 |
Key People
Founding team and executive leadership
MetalloBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Medical Research Council | Grant |
| Oxford Technology | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 31% MoM.
- May 27, 2026
$530K raised with Oxford Technology participating.
MetalloBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about MetalloBio's valuation, stock price, and market status.
Is MetalloBio a public or private company?
MetalloBio is a private company.
What is the current stock price of MetalloBio?
MetalloBio is a private company with no public stock price. No recent secondary market data is available.
How much is MetalloBio worth (valuation)?
MetalloBio's valuation is estimated at $5.1M based on funding round data.
Can I buy MetalloBio stock?
MetalloBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was MetalloBio's last funding round?
MetalloBio's most recent funding round was Early Funding on December 19, 2024.
Who are the main investors in MetalloBio?
Key investors in MetalloBio include Innovate UK, Medical Research Council, Oxford Technology.
Will MetalloBio IPO soon?
No public IPO plans have been announced for MetalloBio.
How can I track MetalloBio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MetalloBio's secondary market activity and sign up for updates.